Characterization of β-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivo

This publication has 25 references indexed in Scilit:

• Alternative splicing generates two isoforms of the β₃‐adrenoceptor which are differentially expressed in mouse tissues
  British Journal of Pharmacology, 1999
• Advances in the pharmacological control of the bladder
  Experimental Physiology, 1999
• Possible β3‐adrenoceptor‐mediated relaxation of the human detrusor
  Acta Physiologica Scandinavica, 1998
• In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a β3-adrenoceptor-mediated effect
  European Journal of Pharmacology, 1998
• Lipolytic effects of conventional β₃‐adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative β₄‐adrenoceptor
  British Journal of Pharmacology, 1997
• Functional evidence of atypical β₃‐adrenoceptors in the human colon using the β₃‐selective adrenoceptor antagonist, SR 59230A
  British Journal of Pharmacology, 1996
• Distribution of β3-adrenoceptor mRNA in human tissues
  European Journal of Pharmacology: Molecular Pharmacology, 1995
• Functional Evidence for the Presence of β3-Adrenoceptors in the Guinea Pig Common Bile Duct and Colon
  Pharmacology, 1995
• Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agent
  Journal of Medicinal Chemistry, 1992
• The brown adipocyte β-adrenoceptor
  Proceedings of the Nutrition Society, 1989